Latest Oxysure Systems (OXYS) Headlines
OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture
ACCESSWIRE - Mon Mar 10, 8:01AM CDT
Whitefish, MT / March 10, 2014 / The healthcare industry has been attracting record amounts of capital in 2014, driven by biotechnology and pharmaceutical companies bringing new products to market. In fact, more than half of all money flowing into U.S. sector-focused ETFs, or $4.06 billion through February 28th, was placed in healthcare ETFs, according to data compiled by Bloomberg.
OxySure CEO Provides Shareholders With a "State of the Union" Communication
Marketwire Canada - Mon Mar 03, 8:20AM CST
OxySure Systems, Inc. (OTCQB: OXYS), ("OxySure," or the "Company"), the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, announced today the release of a company overview as presented by OxySure's CEO Julian Ross.
Medical Device Innovator OxySure Systems Summarizes Recent Corporate Activities - Video News Alert Summary Hosted on InvestmentPitch.com
Newsfile Corp - Wed Feb 19, 10:18AM CST
full story)
Medical Device Innovator OxySure Systems (OTCQB:OXYS) Summarizes Recent Corporate Activities - Video News Alert Summary Hosted on InvestmentPitch.com
Thomson Reuters ONE - Wed Feb 19, 9:32AM CST
Vancouver, BC, February19, 2014 - OxySure Systems (OTCQB:OXYS) a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, has recent corporate activities summarized in a video by InvestmentPitch. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems.
Bringing Oxygen from First Response to Public Places
ACCESSWIRE - Tue Feb 18, 8:56AM CST
Emergency oxygen can help improve hypoxia - or insufficient oxygen reaching the cells - and reduce pain and breathing discomfort during breathing and cardiac emergencies. In a 2008 audit of oxygen use in ambulances and emergency departments in the U.K., researchers found that oxygen use in ambulances is very common at 2.2 million episodes each year.
OxySure De-Leverages to Improve Shareholder Value and Prepares for an Uplisting
ACCESSWIRE - Mon Feb 03, 9:38AM CST
OxySure Systems Inc. (OTCBB: OXYS), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, recently announced that it removed approximately $967,609 of claimed indebtedness from its balance sheet by converting notes and other indebtedness to restricted common stock at above-market conversion prices of between $0.76 and $1.50 per share.
OxySure Systems (OXYS) to Present at SeeThruEquity Microcap Investor Conference
Marketwire - Mon Feb 03, 8:25AM CST
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that CEO Julian T. Ross will present at the SeeThruEquity Microcap Investor Conference on Thursday, February 6, 2014 at 2:30 pm EST. The Conference will be held at Convene Midtown East (730 Third Avenue) in midtown Manhattan, New York.
OxySure Systems (OXYS) Announces Investor Update Conference Call
Marketwire - Fri Jan 31, 8:25AM CST
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that the Company will host a conference call to update shareholders and other interested parties on Tuesday, February 4, 2014 at 10:30 a.m. Central Time - 11:30 a.m. Eastern Time. Julian T. Ross, Chief Executive Officer and President, will provide a brief update and overview.
S&P Capital IQ Initiates Coverage on OxySure Systems, Inc. in S&P Capital IQ Factual Stock Reports
PR Newswire - Tue Jan 28, 8:36AM CST
S&P Capital IQ announced today that it has commenced Standard & Poor's Factual Stock Report coverage on OxySure Systems, Inc.
OxySure Systems (OXYS) Improves Balance Sheet by Reducing Debt by Nearly $1 Million
Marketwire - Mon Jan 27, 8:25AM CST
OxySure® Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, today announced that the Company has removed approximately $967,609 of claimed indebtedness from its balance sheet by converting notes and other indebtedness to restricted common stock at conversion prices ranging from $1.50 per share to $.76 per share.
OxySure Systems, Inc. (OXYS) Information to be Available Through S&P Capital IQ's Market Access Program
Marketwire - Wed Jan 22, 8:25AM CST
OxySure Systems, Inc. (OTCQB: OXYS) announced today that its company information will be made available via S&P Capital IQ's Market Access Program, an information distribution service that enables subscribing publicly traded companies to have their company information disseminated to users of S&P Capital IQ's MarketScope Advisor. The company information to be made available through this program includes share price, volume, dividends, shares outstanding, company financial position, and earnings. MarketScope Advisor is an Internet-based research engine used by more than 100,000 investment advisors. A public version of the site is available at http://advisor.marketscope.com
OxySure Systems (OXYS) to Attend the 32nd Annual J.P. Morgan HealthCare Conference in San Francisco
Marketwire - Thu Jan 09, 2:58PM CST
OxySure® Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, today announced that its CEO Mr. Julian T. Ross will attend the 32nd Annual J.P. Morgan HealthCare Conference on January 13-16, 2014 at the Westin St. Francis in San Francisco to hold discussions with industry leaders regarding the potential of mass deployment of innovative, non-compressed and safe emergency oxygen solutions to lay rescuer markets.
OxySure Systems (OXYS) Closes $750,000 Institutional Private Placement
GlobeNewswire - Thu Jan 02, 10:28AM CST
via PRWEB -- OxySure(R) Systems, Inc. (OXYS: OTCQB) ("OxySure," or the "Company"), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, today announced that it has closed a $750,000 private placement with accredited institutional investors.
Ginguro Provides Clarifying Disclosure on Eastern Reef and 007 Zone
Marketwire Canada - Thu Dec 19, 3:15PM CST
Ginguro Exploration Inc. (TSX VENTURE:GEG) (the "Company") is providing the following clarification regarding previously disclosed results of channel sampling from the Eastern Reef and 007 Zone discovery areas. This clarification pertains to press releases issued by Ginguro on August 15th and 29th, 2013 and on September 6th and 24th, 2013.
OxySure Systems (OXYS) Expands to Hong Kong and Macau
Marketwire - Wed Dec 18, 8:25AM CST
OxySure® Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, today announced that Pacific Medical Systems, Ltd. has signed an agreement to be the Company's exclusive distributor for OxySure's products in Hong Kong and Macau.
OxySure Systems Receives $2.10 Price Target from Taglich Brothers
ACCESSWIRE - Mon Dec 16, 3:00PM CST
OxySure Systems, Inc. (OTCQB: OXYS), a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions, has made a lot of progress signing new distributors and growing its top- and bottom-line financial results over the past few months. Despite management's strong performance, the stock remains significantly undervalued by many measures as highlighted in a recent research report.
OxySure Systems (OXYS) Adds Chile to Fast Growing Global Distribution Footprint
Marketwire - Wed Dec 11, 8:25AM CST
OxySure® Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, today announced that it has signed a distribution agreement with TecnologÃa Contra Incendios Python E.I.R.L. ("Python") to represent OxySure in the country of Chile in South America. This is the first distribution agreement announced by OxySure post-Medica 2013, the international medical tradeshow where the Company exhibited in Dusseldorf, Germany during November 2013.
OxySure Systems (OXYS) Announces Update From Medica 2013 Trade Fair
Marketwire - Thu Dec 05, 8:25AM CST
OxySure® Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), announced today an update from the Medica 2013 Trade Fair in Dusseldorf, Germany, the largest medical device trade show in world, with approximately 130,000 attendees per day over the four day trade fair. (www.medica-tradefair.com) OxySure, co-exhibiting with Medizon B.V., its partner in the Netherlands, experienced a high volume of inquiries regarding its proprietary respiratory solutions. As a result several different countries have begun negotiations on distribution agreements to expand the OxySure brand and products.
OxySure Systems (OXYS) Reports Third Quarter 2013 Results
Marketwire - Thu Nov 14, 8:15AM CST
OxySure®Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), today reported financial and operating results for the third quarter ended September 30, 2013.
Oxygen Biotherapeutics (OXBT) Rise Sheds Light On OxySure Systems (OXYS)
ACCESSWIRE - Thu Nov 07, 10:59AM CST
Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) has risen more than 175% over the past week or so on massive trading volumes, after announcing a broadening of their product lines through a licensing agreement.
OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture
ACCESSWIRE - Mon Mar 10, 8:01AM CDT
Whitefish, MT / March 10, 2014 / The healthcare industry has been attracting record amounts of capital in 2014, driven by biotechnology and pharmaceutical companies bringing new products to market. In fact, more than half of all money flowing into U.S. sector-focused ETFs, or $4.06 billion through February 28th, was placed in healthcare ETFs, according to data compiled by Bloomberg.
OxySure CEO Provides Shareholders With a "State of the Union" Communication
Marketwire Canada - Mon Mar 03, 8:20AM CST
OxySure Systems, Inc. (OTCQB: OXYS), ("OxySure," or the "Company"), the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, announced today the release of a company overview as presented by OxySure's CEO Julian Ross.
Medical Device Innovator OxySure Systems Summarizes Recent Corporate Activities - Video News Alert Summary Hosted on InvestmentPitch.com
Newsfile Corp - Wed Feb 19, 10:18AM CST
full story)
Medical Device Innovator OxySure Systems (OTCQB:OXYS) Summarizes Recent Corporate Activities - Video News Alert Summary Hosted on InvestmentPitch.com
Thomson Reuters ONE - Wed Feb 19, 9:32AM CST
Vancouver, BC, February19, 2014 - OxySure Systems (OTCQB:OXYS) a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, has recent corporate activities summarized in a video by InvestmentPitch. The company owns numerous issued patents and patents pending on this technology which makes the provision of emergency oxygen safer, more accessible and easier to use than traditional oxygen provision systems.
Bringing Oxygen from First Response to Public Places
ACCESSWIRE - Tue Feb 18, 8:56AM CST
Emergency oxygen can help improve hypoxia - or insufficient oxygen reaching the cells - and reduce pain and breathing discomfort during breathing and cardiac emergencies. In a 2008 audit of oxygen use in ambulances and emergency departments in the U.K., researchers found that oxygen use in ambulances is very common at 2.2 million episodes each year.
OxySure De-Leverages to Improve Shareholder Value and Prepares for an Uplisting
ACCESSWIRE - Mon Feb 03, 9:38AM CST
OxySure Systems Inc. (OTCBB: OXYS), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, recently announced that it removed approximately $967,609 of claimed indebtedness from its balance sheet by converting notes and other indebtedness to restricted common stock at above-market conversion prices of between $0.76 and $1.50 per share.
OxySure Systems (OXYS) to Present at SeeThruEquity Microcap Investor Conference
Marketwire - Mon Feb 03, 8:25AM CST
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that CEO Julian T. Ross will present at the SeeThruEquity Microcap Investor Conference on Thursday, February 6, 2014 at 2:30 pm EST. The Conference will be held at Convene Midtown East (730 Third Avenue) in midtown Manhattan, New York.
OxySure Systems (OXYS) Announces Investor Update Conference Call
Marketwire - Fri Jan 31, 8:25AM CST
OxySure Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), the medical device innovator of life-saving easy-to-use emergency oxygen solutions with its "oxygen from powder" technology today announced that the Company will host a conference call to update shareholders and other interested parties on Tuesday, February 4, 2014 at 10:30 a.m. Central Time - 11:30 a.m. Eastern Time. Julian T. Ross, Chief Executive Officer and President, will provide a brief update and overview.
S&P Capital IQ Initiates Coverage on OxySure Systems, Inc. in S&P Capital IQ Factual Stock Reports
PR Newswire - Tue Jan 28, 8:36AM CST
S&P Capital IQ announced today that it has commenced Standard & Poor's Factual Stock Report coverage on OxySure Systems, Inc.
OxySure Systems (OXYS) Improves Balance Sheet by Reducing Debt by Nearly $1 Million
Marketwire - Mon Jan 27, 8:25AM CST
OxySure® Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, today announced that the Company has removed approximately $967,609 of claimed indebtedness from its balance sheet by converting notes and other indebtedness to restricted common stock at conversion prices ranging from $1.50 per share to $.76 per share.
OxySure Systems, Inc. (OXYS) Information to be Available Through S&P Capital IQ's Market Access Program
Marketwire - Wed Jan 22, 8:25AM CST
OxySure Systems, Inc. (OTCQB: OXYS) announced today that its company information will be made available via S&P Capital IQ's Market Access Program, an information distribution service that enables subscribing publicly traded companies to have their company information disseminated to users of S&P Capital IQ's MarketScope Advisor. The company information to be made available through this program includes share price, volume, dividends, shares outstanding, company financial position, and earnings. MarketScope Advisor is an Internet-based research engine used by more than 100,000 investment advisors. A public version of the site is available at http://advisor.marketscope.com
OxySure Systems (OXYS) to Attend the 32nd Annual J.P. Morgan HealthCare Conference in San Francisco
Marketwire - Thu Jan 09, 2:58PM CST
OxySure® Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, today announced that its CEO Mr. Julian T. Ross will attend the 32nd Annual J.P. Morgan HealthCare Conference on January 13-16, 2014 at the Westin St. Francis in San Francisco to hold discussions with industry leaders regarding the potential of mass deployment of innovative, non-compressed and safe emergency oxygen solutions to lay rescuer markets.
OxySure Systems (OXYS) Closes $750,000 Institutional Private Placement
GlobeNewswire - Thu Jan 02, 10:28AM CST
via PRWEB -- OxySure(R) Systems, Inc. (OXYS: OTCQB) ("OxySure," or the "Company"), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, today announced that it has closed a $750,000 private placement with accredited institutional investors.
Ginguro Provides Clarifying Disclosure on Eastern Reef and 007 Zone
Marketwire Canada - Thu Dec 19, 3:15PM CST
Ginguro Exploration Inc. (TSX VENTURE:GEG) (the "Company") is providing the following clarification regarding previously disclosed results of channel sampling from the Eastern Reef and 007 Zone discovery areas. This clarification pertains to press releases issued by Ginguro on August 15th and 29th, 2013 and on September 6th and 24th, 2013.
OxySure Systems (OXYS) Expands to Hong Kong and Macau
Marketwire - Wed Dec 18, 8:25AM CST
OxySure® Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, today announced that Pacific Medical Systems, Ltd. has signed an agreement to be the Company's exclusive distributor for OxySure's products in Hong Kong and Macau.
OxySure Systems Receives $2.10 Price Target from Taglich Brothers
ACCESSWIRE - Mon Dec 16, 3:00PM CST
OxySure Systems, Inc. (OTCQB: OXYS), a medical technology company that focuses on the design, manufacture and distribution of specialty respiratory and medical solutions, has made a lot of progress signing new distributors and growing its top- and bottom-line financial results over the past few months. Despite management's strong performance, the stock remains significantly undervalued by many measures as highlighted in a recent research report.
OxySure Systems (OXYS) Adds Chile to Fast Growing Global Distribution Footprint
Marketwire - Wed Dec 11, 8:25AM CST
OxySure® Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, today announced that it has signed a distribution agreement with TecnologÃa Contra Incendios Python E.I.R.L. ("Python") to represent OxySure in the country of Chile in South America. This is the first distribution agreement announced by OxySure post-Medica 2013, the international medical tradeshow where the Company exhibited in Dusseldorf, Germany during November 2013.
OxySure Systems (OXYS) Announces Update From Medica 2013 Trade Fair
Marketwire - Thu Dec 05, 8:25AM CST
OxySure® Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), announced today an update from the Medica 2013 Trade Fair in Dusseldorf, Germany, the largest medical device trade show in world, with approximately 130,000 attendees per day over the four day trade fair. (www.medica-tradefair.com) OxySure, co-exhibiting with Medizon B.V., its partner in the Netherlands, experienced a high volume of inquiries regarding its proprietary respiratory solutions. As a result several different countries have begun negotiations on distribution agreements to expand the OxySure brand and products.
OxySure Systems (OXYS) Reports Third Quarter 2013 Results
Marketwire - Thu Nov 14, 8:15AM CST
OxySure®Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), today reported financial and operating results for the third quarter ended September 30, 2013.
Oxygen Biotherapeutics (OXBT) Rise Sheds Light On OxySure Systems (OXYS)
ACCESSWIRE - Thu Nov 07, 10:59AM CST
Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) has risen more than 175% over the past week or so on massive trading volumes, after announcing a broadening of their product lines through a licensing agreement.
